Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Dec;20(12):1493-1501.
doi: 10.1007/s12094-018-1887-3. Epub 2018 May 23.

This is a call to oncologists for action

Affiliations
Review

This is a call to oncologists for action

C Micó et al. Clin Transl Oncol. 2018 Dec.

Abstract

Cancer cases are growing in an exponential way, likewise the prices of new cancer drugs. Continuing in this way, in the near future, it will be impossible to provide optimum care for all cancer patients. Therefore, it is important to establish mechanisms that enable the National Health Systems to provide the best options of treatment, either through the elaboration of decision-binding frameworks or through other initiatives that guarantee the best quality care for all oncology patients to overcome, in the best possible way, this difficult illness. Here, we review current proposals that have been established by different cancer organizations worldwide, their similarities, their differences and whether they are helpful in a real clinical setting. Facing present reality and despite these organizations' huge efforts, these proposals are not being implemented at all and it does not seem feasible that they will in the short run. In the same way, we support and argue why oncologists should have a crucial and a preponderant role to establish the best way of guaranteeing an equal access to the latest oncology care.

Keywords: ASCO score; CanCon Project; Cancer costs; Cancer value; Drug Abacus; ESMO score; Evidence blocks; Frameworks tools; Health costs; Health economics; OncoSim; Oncologists.

PubMed Disclaimer

References

    1. Int J Cancer. 2015 Mar 1;136(5):E359-86 - PubMed
    1. J Oncol Pract. 2017 Jul;13(7):e653-e665 - PubMed
    1. Ann Oncol. 2017 Oct 1;28(10):2340-2366 - PubMed
    1. N Engl J Med. 2012 Oct 25;367(17):1616-25 - PubMed
    1. Ann Oncol. 2017 May 1;28(5):1111-1116 - PubMed

Substances

LinkOut - more resources